Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Arjowiggins launches Biomaster protected papers

Arjowiggins Group Ltd, the global manufacturer of famous brand names in paper, has launched an antimicrobial surface treatment for paper products with Biomaster technology. In independent testing to ISO 21702, the papers saw reduction in human Coronavirus in as little as just one hour. The new antimicrobial solution from Arjowiggins proactively inhibit the growth of harmful microbes for the intended lifetime of the product The solution is added to paper products during manufacture to ensure particles are more concentrated at the surface of the paper. It then works to interrupt cell

The Dutch ministries extend contract with Sectra for secure communication as a service

Linköping, Sweden – May 20, 2021 – The Dutch ministries have renewed their contract with international cybersecurity and medical imaging IT company Sectra  (STO: SECT B). The contract allows the Dutch ministries to continue to purchase Sectra’s secure communication as a service. The service supports Dutch ministries and government officials in communicating classified information relating to national security without risking the confidentiality of the information. The service covers a range of solutions, which enables the Dutch ministries to offer employees the most

Invitation to presentation of the Q1 2021 results

STOCKHOLM — May 20, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, will publish its report for the first quarter 2021 on May 26. Investors, financial analysts and media are invited to participate in a webcast with a QnA session on the same day at 12:00 CEST. The event will be hosted by CEO, Marty J Duvall and members of the Oncopeptides’ Leadership team. The presentation will be held in English.The webcast will be streamed via this link 

Iconovo and Respiratorius sign agreement for development of inhalation product to treat COPD

Iconovo AB (publ), which develops complete inhalation products for a global market, and Respiratorius AB (publ), which develops drug candidates for the treatment of COPD, and other common diseases, announced today that they have signed an agreement for the development of an inhalation formulation as well as an inhalation product for phase I studies for Respiratorius drug candidate RES030-085 within the RESP9000 project for the treatment of COPD and severe asthma.COPD is considered one of the most common and fastest growing diseases that lack satisfactory treatment. The formulation work

Interim report January – March 2021

Strong start to 2021First quarter, January – March 2021 · Net Sales amounted to SEK 466.2 m (387.8), an increase of 20.2%. · EBITDA before items affecting comparability amounted to SEK 67.6 m (48.5),an increase of 39.3%. The EBITDA margin before items affecting comparabilityamounted to 14.5% (12.5). · EBITDA amounted to SEK 63.7 m (45.3), an increase of 40.7%. The EBITDAmargin amounted to 13.7% (11.7). · Operating profit (EBIT) amounted to SEK 33.7 m (22.1), an increase of52.4%. The operating margin amounted to 7.2% (5.7). · Net profit for the quarter amounted to

Interim Report January-March 2021

ChromoGenics received an order of SEK 23.3 million from NorwayQ1 2021 · In the first quarter, order intake amounted to SEK 24.7 (7.4) million, an increase of 234 percent compared to the corresponding period in 2020. An order totaling SEK 23.3 million and with delivery in the fall of 2021 was received in March from Betonmast Oslo AS in Norway for the products ConverLight® Dynamic and ConverLight® Paragon ECO for installation in an environmentally certified building that is being built at Gullhaugs Torg 5 in Oslo, Norway. Repeat customer Humlegården placed an order of around SEK 0.8

Q1 2021 Report: Scandion Oncology is evolving

Scandion Oncology A/S (”Scandion Oncology” or “the Company”) hereby publishes the Q1 2021 Report for the period January 1 – March 31, 2021. Bo Rode Hansen, President & CEO, Scandion Oncology A/S comments:“Scandion Oncology is evolving. Clinical progress and strengthening of the organization have marked the first quarter of 2021. With key hires in R&D, advisory roles, and business development we are building the organization with the competences needed to be ready for the upcoming milestones - the part 1 of the phase II CORIST study in Q2 2021, followed by a planned readout from the

Endomines AB Q1 2021 Business Review Preparation underway for Restart of the Friday Mine and Mill

Endomines AB, Stock Exchange Release 20 May 2021 at 08:30 CEST Jan-Mar 2021 (Jan-Mar 2020) Operational highlights · A Director of Operations has been recruited to oversee and lead the development of the company’s operations. At Friday, a General Manager was hired to focus on the onsite re-start and lead the operation into a steady state. · Technical challenges at the Orogrande Processing Facility have been resolved and the summer start-up program is on track. · During care and maintenance, we successfully completed the dewatering at Friday mine that will allow stope

Interim Report January - March 2021

January 1[st] – March 31[st] 2021 · Net sales amounted to EUR 5 691 thousand (4 881) · EBITDA of EUR 49 thousand (4) and EBITDA margin of 0.9 % (0.1) · EBIT of negative EUR 48 thousand (-93) and EBIT margin of -0.8% (-1.9) · Net earnings after tax of negative EUR 339 thousand (-527) January ­– March key developments · Group performance exceeded expectations in spite of lingering Covid-challenges · Total Revenue passed a EUR 2M in March · The IoT Revenue reached 18% of the total Revenue · Both IoT companies (TPAB and HS) showed profit · Strong come back in

Dignitana AB Publishes Q1 2021 Interim Report

Reopening and reimbursement progress   Financial highlights Q1 2021 ·Net sales amounted to 13,2 MSEK (11,4), an increase of 16 percent over the same period 2020 · Operating result amounted to -7,1 MSEK (-12,5) · Net result after financial items amounted to -7,7 MSEK (-12,8) · Earnings per share was -0,12 SEK (-0,23) · Cash Balance amounted to 44,4 MSEK (8,8) · Average Daily Treatment Revenue (ADTR)* was 130 TSEK (118), an increase of 10 percent over the same period in 2020 Significant events during the period ·The Extraordinary General Meeting on

Today is first day of trading in Checkin.com Group shares on Nasdaq First North Growth Market

Checkin.com Group AB (publ) (“Checkin.com” or “the Company”) today celebrates the first day of trading of its shares on Nasdaq First North Growth Market. The Company’s share is traded under the trading symbol "CHECK" with the ISIN code SE0015810502.Checkin.com, a fast-growing SaaS company with the goal to establish a new internet standard for checkins, completed a heavily oversubscribed share issue during May 2021 through which the Company raised SEK 45.0 million before issue costs. The share issue was oversubscribed by over 2 000 percent, corresponding to a total subscription value of SEK

American Shipping Company ASA - First quarter 2021 results

Lysaker, 20 May 2021, American Shipping Company ASA (“AMSC” or the “Company”) announces results for first quarter ending 31 March 2021. HIGHLIGHTS · Stable Q1 financial performance with bareboat revenue of USD 21.7 million, normalized EBITDA of USD 21.3 million and adjusted net profit of USD 5.4 million · Backlog of secured bareboat revenue of USD 214 million with average weighted tenor of 2.4 years · Declared Q1 dividend of USD 0.10 per share, backed by the Company’s free cash flow · Subsequent to quarter-end, the Company executed a USD 20 million tap issue under the

CELLINK has acquired Visikol, a contract research services company focused on advanced imaging, 3D cell culture assays and digital pathology

CELLINK has acquired Visikol Corp., an American contract research services company offering leading services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharma and biotech companies. CELLINK has acquired all outstanding shares in Visikol for a purchase price of $7.5 million on a cash- and debt-free basis under the assumption that the working capital at closing equals the normalized working capital at closing of which approximately $2.5 million will be paid in 57,911 newly issued shares of series B in CELLINK at a price of SEK 357.60 per share (

Sivers Semiconductors AB (publ), Interim Report Q1, January – March 2021

First quarter 2021 · Revenue amounted to SEK 13.840 M (22.810), a decrease of 39% · Profit before depreciation and amortization (EBITDA) amounted to SEK -17.771 M (-11.001) · Operating profit/loss (EBIT) for the period was SEK -25.802 M (-18.459) · Profit/loss after tax was SEK -26.233 M (-21.217) · Earnings per share before and after dilution was SEK -0.17 (-0.16) · Equity per share amounted to SEK 3.32 (2.34)Significant events in the first quarter: · On January 11, Pelle Wijk was appointed MD of the subsidiary Sivers Wireless. · On January 11, Sivers

MPC Container Ships Invest B.V. reports Q1 and three-month 2021 results

Oslo/Rhoon, 20 May 2021 - MPC Container Ships Invest B.V. (the "Company", together with its subsidiaries the "Group") today published its unaudited financial report for the three-month period ended 31 March 2021. The Group reported a net loss of USD 1.0 million for Q1 2021 (Q4 2020: net loss of USD 14.4 million). As at 31 March 2021, the Group owns 36 container vessels between 1,000 – 2,800 TEU, of which one vessel is classified as held for sale with expected delivery to new owners in H1 2021. Further information and contact: ir@mpc-container.com About MPC Container Ships Invest

Eurobattery Minerals AB hereby publishes its Interim Report January – March 2021

First quarter 2021 (same period previous year) · Net sales amounted to SEK 0 thousand (SEK 0 thousand). · Operating income after financial items totalled SEK –2,721 thousand (SEK –2,248 thousand). · Earnings per share after financial items amounted to SEK –0.17 (SEK –0.14). · Cash flow from operating activities was SEK –2,048 thousand (SEK –2,522 thousand). Significant events during the first quarter · Eurobattery Minerals has announced that it intends to expand to Börse Stuttgart, under the ticker symbol EBM, by extending its listing from Nordic Growth Market (

ALL-TIME HIGH REVENUE AND IMPROVED PROFITABILITY

This is a translation of the Swedish interim report. If there should be any discrepancies, the Swedish language version governs.   FIRST QUARTER, JANUARY– MARCH 2021 · Net sales increased by 3.1%, or 5.3% FX adjusted, to MSEK 71.6 (69.4) · Gross profit increased by 3.0%, or 5.8% FX adjusted, to MSEK 53.8 (52.2) · EBIT increased to MSEK 6.5 (-0.3) · Earnings after tax was MSEK 7.3 (0.4) · Earnings per share was, basic SEK 0.93 (0.06), diluted SEK 0.93 (0.06)  IMPORTANT EVENTS DURING THE PERIOD        · The board of directors decided on a new strategy for

Fazer celebrates its 130th anniversary with an assortment of favourite Fazer products from every decade of its existence

I höst, den 17 september 2021, är det 130 år sedan den unge, djärve Karl Fazer grundade ett fransk-ryskt konditori på Glogatan i Helsingfors. Karls mål var att skapa mat med mening: skapa stunder av glädje för alla människor runtomkring honom. Under de första åren rymdes Fazers samtliga medarbetare runt samma matbord, men under årens lopp har verksamheten vuxit och blivit ett ikoniskt finländskt företag med fokus på matupplevelser. I dag sysselsätter Fazer 8 500 medarbetare i åtta länder och tillverkar bageriprodukter, konfektyr, non-dairy produkter och växtbaserade livsmedel.Boxen Fazer

Ratos and other owners considering diversifying ownership of Aibel

Aibel’s owners, including Ratos AB (publ) (“Ratos”), are considering the possibility of diversifying the company’s ownership, preferably through a listing on the Oslo Børs, in order to further accelerate its transition into the renewable energy industry. However, a final decision has not been taken.Ratos currently owns 32% of Aibel. The other owners are Ferd (50%) and Sixth AP Fund (18%). “Aibel has undergone an outstanding transition over the past five years with Mads Anderson as CEO. Its operations are stable, and half of the order book now comprises projects related to offshore wind

Board members of Qlife subscribe for warrants

The subscription period in Qlife's directed issue of warrants to board members ended on May 17, 2021. Board members subscribed a total of 40,000 warrants for the price of SEK 6.11 per warrant.At the Annual General Meeting on May 5, 2021, an incentive program aimed at three new board members of the company was resolved.  The warrant terms are based on a market valuation according to Black Scholes, based on the volume-weighted price May 6, 2021 through May 12, 2021. The terms mean that a warrant subscribed for at the price of SEK 6.11 can be redeemed against a new share with a strike price of

Realfiction Holding AB publishes its 2020 Annual Report

Realfiction Holding AB (publ) (“Realfiction” or the “Company”) is pleased to publish its 2020 Annual Report for the year ended 31 December 2020. The Annual Report is available on the Company’s website, www.realfiction.com. A printed copy can be ordered via investor@realfiction.com.For more information about Realfiction Holding AB, please contact:Clas Dyrholm, founder and CEO Telephone: +45 25 22 32 81Email: clas@realfiction.comwww.realfiction.com Certified AdviserMangold Fondkommission AB is the company's Certified Adviser and can be contacted via ca@mangold.se or +46 8 503 015

Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast

Oslo, Norway, 20 May 2021 Nordic Nanovector ASA (OSE: NANOV) announces that it will report its results for the first quarter 2021 on Wednesday, 26 May 2021. A presentation by Nordic Nanovector’s senior management team will be webcast live the same day at 8:30am CET. The webcast can be accessed from www.nordicnanovector.com in the section: Investors & Media and a recording will also be available on this page after the event. The results report and the presentation will be available at www.nordicnanovector.com in the section: Investors & Media/Reports and Presentation/Interim

There are no items matching the current filter
There are no more items matching the current filter
Back to top